Allergy Asthma Respir Dis.  2019 Oct;7(4):173-178. 10.4168/aard.2019.7.4.173.

The association between asthma and Kawasaki disease

• Choi BS

• KMID: 2461393
• DOI: http://doi.org/10.4168/aard.2019.7.4.173

Abstract

Kawasaki disease (KD) is a systemic vasculitis and the most common cause of acquired heart disease among preschool-aged children. Asthma is one of the most common chronic illness of childhood. There is increasing interest in the potential link between inflammatory diseases and allergic diseases, and there is increasing epidemiologic evidence for an association of KD and allergic disease. In regards to asthma, 9 studies have been reported about its association with KD; 5 of them showed positive associations between these 2 diseases, while 4 of them showed no association. There are some possible underlying mechanisms for this association. The serum IgE levels are found to be increased and there is a Th2-predominant immune response in KD. These are common findings of asthma. Human leukocyte antigen-G/regT cells and SMAD3/transforming growth factor-beta might also be involved in the pathogenesis of both diseases. Asthma may increase susceptibility to KD and tends to lead to immune dysregulation. Clinician's recognition of the increased risks of KD and other asthma-related comorbidities among patients with asthma may enable early identification and intervention. The early identification and management of comorbidities may ultimately reduce the economic and social burden of these chronic conditions.

Keyword

Kawasaki disease; Mucocutaneous lymph node syndrome; Allergy; Asthma; Comorbidity

MeSH Terms

Asthma*
Child
Chronic Disease
Comorbidity
Heart Diseases
Humans
Hypersensitivity
Immunoglobulin E
Leukocytes
Mucocutaneous Lymph Node Syndrome*
Systemic Vasculitis
Immunoglobulin E

Reference

References

1. Kim GB, Park S, Eun LY, Han JW, Lee SY, Yoon KL, et al. Epidemiology and clinical features of Kawasaki disease in South Korea, 2012–2014. Pediatr Infect Dis J. 2017; 36:482–5.

2. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996; 94:1379–85.

3. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993; 87:1776–80.

4. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004; 110:2747–71.

5. Chang RK. The incidence of Kawasaki disease in the United States did not increase between 1988 and 1997. Pediatrics. 2003; 111(5 Pt 1):1124–5.

6. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics. 2003; 112(3 Pt 1):495–501.

7. Maddox RA, Holman RC, Uehara R, Callinan LS, Guest JL, Schonberger LB, et al. Recurrent Kawasaki disease: USA and Japan. Pediatr Int. 2015; 57:1116–20.

8. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012; 12:204.

9. Lee SI. Prevalence of childhood asthma in Korea: international study of asthma and allergies in childhood. Allergy Asthma Immunol Res. 2010; 2:61–4.

10. Braman SS. The global burden of asthma. Chest. 2006; 130(1 Suppl):4S–12S.

11. Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, et al. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013; 310:591–608.

12. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol. 1999; 17:255–81.

13. Kwon HJ, Bang DW, Kim EN, Wi C, Yawn BP, Wollan PC, et al. Asthma as a risk factor for zoster in adults: a population-based case-control study. J Allergy Clin Immunol. 2016; 137:1406–12.

14. Wi CI, Kim BS, Mehra S, Yawn BP, Park MA, Juhn YJ. Risk of herpes zoster in children with asthma. Allergy Asthma Proc. 2015; 36:372–8.

15. Sheen YH, Rolfes MC, Wi CI, Crowson CS, Pendegraft RS, King KS, et al. Association of asthma with rheumatoid arthritis: a population-based case-control study. J Allergy Clin Immunol Pract. 2018; 6:219–26.

16. Bang DW, Wi CI, Kim EN, Hagan J, Roger V, Manemann S, et al. Asthma status and risk of incident myocardial infarction: a population-based case-control study. J Allergy Clin Immunol Pract. 2016; 4:917–23.

17. Patel B, Wi CI, Hasassri ME, Divekar R, Absah I, Almallouhi E, et al. Heterogeneity of asthma and the risk of celiac disease in children. Allergy Asthma Proc. 2018; 39:51–8.

18. Brosius CL, Newburger JW, Burns JC, Hojnowski-Diaz P, Zierler S, Leung DY. Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J. 1988; 7:863–6.

19. Matsuoka S, Tatara K, Nakagawa R, Mori K, Kuroda Y. Tendency toward atopy in Kawasaki disease. Eur J Pediatr. 1997; 156:30–2.

20. Liew WK, Lim CW, Tan TH, Wong KY, Tai BC, Quek SC, et al. The effect of Kawasaki disease on childhood allergies – a sibling control study. Pediatr Allergy Immunol. 2011; 22:488–93.

21. Webster RJ, Carter KW, Warrington NM, Loh AM, Zaloumis S, Kuijpers TW, et al. Hospitalisation with infection, asthma and allergy in Kawasaki disease patients and their families: genealogical analysis using linked population data. PLoS One. 2011; 6:e28004.

22. Kuo HC, Chang WC, Yang KD, Yu HR, Wang CL, Ho SC, et al. Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study. BMC Pediatr. 2013; 13:38.

23. Woon PY, Chang WC, Liang CC, Hsu CH, Klahan S, Huang YH, et al. Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in taiwan. Evid Based Complement Alternat Med. 2013; 2013:605123.

24. Hwang CY, Hwang YY, Chen YJ, Chen CC, Lin MW, Chen TJ, et al. Atopic diathesis in patients with Kawasaki disease. J Pediatr. 2013; 163:811–5.

25. Tsai YJ, Lin CH, Fu LS, Fu YC, Lin MC, Jan SL. The association between Kawasaki disease and allergic diseases, from infancy to school age. Allergy Asthma Proc. 2013; 34:467–72.

26. Hassidim A, Merdler I, Chorin O, Merdler-Rabinowicz R, Dallal I, Perlman M, et al. Atopic predilection among Kawasaki disease patients: a cross-sectional study of 1,187,757 teenagers. Int Arch Allergy Immunol. 2016; 170:92–6.

27. Nakamura T, Nakamura T, Ko G, Yamashita Y, Akita C, Saikawa Y. Over 5 years follow-up of kawasaki disease with atopic bronchial asthma. Circulation. 2015; 131(suppl 2):Abstract No. 205.

28. Wei CC, Lin CL, Kao CH, Liao YH, Shen TC, Tsai JD, et al. Increased risk of Kawasaki disease in children with common allergic diseases. Ann Epidemiol. 2014; 24:340–3.

29. Masood S, Manlhiot C, Chahal N, Yeung R, Mccrindle B. Environmental exposures and Kawasaki disease: the infectious trigger hypothesis. Pediatr Int. 2012; 54:64.

30. White SR, Loisel DA, Stern R, Laxman B, Floreth T, Marroquin BA. Human leukocyte antigen-G expression in differentiated human airway epithelial cells: lack of modulation by Th2-associated cytokines. Respir Res. 2013; 14:4.

31. Carlini F, Picard C, Garulli C, Piquemal D, Roubertoux P, Chiaroni J, et al. Bronchial epithelial cells from asthmatic patients display less functional HLA-G isoform expression. Front Immunol. 2017; 8:6.

32. Kim JJ, Hong SJ, Hong YM, Kim S, Kang MJ, Kim KJ, et al. Genetic variants in the HLA-G region are associated with Kawasaki disease. Hum Immunol. 2008; 69:867–71.

33. Ni FF, Li CR, Li Q, Xia Y, Wang GB, Yang J. Regulatory T cell microRNA expression changes in children with acute Kawasaki disease. Clin Exp Immunol. 2014; 178:384–93.

34. Howell JE, McAnulty RJ. TGF-beta: its role in asthma and therapeutic potential. Curr Drug Targets. 2006; 7:547–65.

35. Makinde T, Murphy RF, Agrawal DK. The regulatory role of TGF-beta in airway remodeling in asthma. Immunol Cell Biol. 2007; 85:348–56.

36. Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, Molkara D, et al. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet. 2011; 4:16–25.

37. Shimizu C, Oharaseki T, Takahashi K, Kottek A, Franco A, Burns JC. The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol. 2013; 44:189–98.

38. Kuo HC, Wang CL, Liang CD, Yu HR, Huang CF, Wang L, et al. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease. Pediatr Allergy Immunol. 2009; 20:266–72.

39. Furukawa S, Matsubara T, Motohashi T, Sasai K, Nakachi S, Umezawa Y, et al. Increased expression of Fc epsilon R2/CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease. Int Arch Allergy Appl Immunol. 1991; 95:7–12.

40. Terai M, Yasukawa K, Honda T, Jibiki T, Hirano K, Sato J, et al. Peripheral blood eosinophilia and eosinophil accumulation in coronary microves-sels in acute Kawasaki disease. Pediatr Infect Dis J. 2002; 21:777–81.

41. Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res. 2001; 2:10–9.

42. Gualano RC, Vlahos R, Anderson GP. What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease? Pulm Pharmacol Ther. 2006; 19:18–23.

43. Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J. 2002; 19:68–75.

44. Biezeveld MH, van Mierlo G, Lutter R, Kuipers IM, Dekker T, Hack CE, et al. Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin Exp Immunol. 2005; 141:183–8.